- Home
- TOP vs ABVC Comparison
TOP vs ABVC Comparison
Compare TOP & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOP
- ABVC
- Stock Information
- Founded
- TOP 2015
- ABVC 2015
- Country
- TOP Hong Kong
- ABVC United States
- Employees
- TOP N/A
- ABVC N/A
- Industry
- TOP Investment Bankers/Brokers/Service
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- TOP Finance
- ABVC Health Care
- Exchange
- TOP Nasdaq
- ABVC Nasdaq
- Market Cap
- TOP 46.0M
- ABVC 52.1M
- IPO Year
- TOP 2022
- ABVC N/A
- Fundamental
- Price
- TOP $1.23
- ABVC $3.01
- Analyst Decision
- TOP
- ABVC
- Analyst Count
- TOP 0
- ABVC 0
- Target Price
- TOP N/A
- ABVC N/A
- AVG Volume (30 Days)
- TOP 49.1K
- ABVC 729.3K
- Earning Date
- TOP 08-05-2025
- ABVC 08-13-2025
- Dividend Yield
- TOP N/A
- ABVC N/A
- EPS Growth
- TOP N/A
- ABVC N/A
- EPS
- TOP N/A
- ABVC N/A
- Revenue
- TOP $2,730,890.00
- ABVC $508,383.00
- Revenue This Year
- TOP N/A
- ABVC $735.18
- Revenue Next Year
- TOP N/A
- ABVC N/A
- P/E Ratio
- TOP N/A
- ABVC N/A
- Revenue Growth
- TOP N/A
- ABVC 1904.43
- 52 Week Low
- TOP $1.00
- ABVC $0.40
- 52 Week High
- TOP $1.94
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- TOP 46.96
- ABVC 50.14
- Support Level
- TOP $1.18
- ABVC $2.91
- Resistance Level
- TOP $1.25
- ABVC $3.39
- Average True Range (ATR)
- TOP 0.05
- ABVC 0.58
- MACD
- TOP -0.00
- ABVC -0.14
- Stochastic Oscillator
- TOP 37.82
- ABVC 3.89
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.